Monday 18 December 2017

In-Vitro Colorectal Cancer Screening Tests Market to grow at over 5% CAGR from 2016 to 2023

The research report In-Vitro Colorectal Cancer Screening Tests Market Size By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, by Global Market Insights, Inc., says In-vitro colorectal cancer screening tests industry size is estimated to hit USD 903 million by 2023.

Technological developments in healthcare to acquire accurate results in early diagnosis will propel in-vitro colorectal cancer screening tests market size over the coming years. Furthermore, government legislations mandating cancer diagnosis and screening are expected to boost the market trends. For instance, EU collaborated with IARC (International Agency for Research on Cancer) to produce the first edition of quality assurance guidelines for colorectal cancer diagnosis and screening to improve the quality of cancer diagnosis. Moreover, rise in the geriatric population base, prone to chronic diseases, along with the escalating occurrence of colon and rectal cancer is expected to favorably impact in-vitro colorectal cancer screening tests market growth over the next few years. In addition to this, growing awareness about early diagnosis of colorectal cancer will noticeably enhance the industry outlook.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/451

Order This Report by calling Global Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.

The differentiating factor of in-vitro colorectal cancer screening tests market report by Global Market Insights, Inc. when compared with other, similar syndicated research studies includes a 360-degree synopsis of trends for a period of more than 10 years including historic information as well as future outlook. Business focussed multiple trends for in-vitro colorectal cancer screening tests industry are discussed along with regional trends to offer an overall view of the market. The ‘industry insights’ chapter of this research provides the most comprehensive analysis of in-vitro colorectal cancer screening tests market covering segmentation, size, forecasts, ecosystem analysis and more. Industry impact forces (regional and global) that cover growth drivers and challenges, growth potential analysis, a strategy dashboard for competitive landscape of in-vitro colorectal cancer screening tests market support this sector specific data and information points.

Rising popularity of fecal occult blood tests is projected to boost in-vitro colorectal cancer screening tests industry share over 2016-2023:

Taking into consideration the tests trends, in-vitro colorectal cancer screening tests market is segmented into biomarker tests, fecal occult blood tests, and colorectal cancer(CRC) DNA screening tests. Growing use of Immuno- fecal occult blood agglutination as well as Immuno- fecal occult blood ELISA tests for early and quick detection of colorectal cancer will boost FOB tests market size, having attained targeted revenue of over USD 500 million in 2015. Colorectal cancer (CRC) DNA screening tests market size is expected to grow at a rate of 10% over the period of 2016-2023, owing to high level of test accuracy and sensitivity.


https://www.gminsights.com/industry-analysis/in-vitro-colorectal-cancer-screening-tests-market-report

Asia Pacific is expected to drive in-vitro colorectal cancer screening tests industry revenue by 2023:
Considering the regional outlook, North America in-vitro colorectal cancer screening tests market, which dominated the regional landscape in 2015, is projected to witness a considerable growth over the coming years, driven by rise in healthcare spending, enhanced healthcare amenities, high level of patient awareness, and introduction of supportive government legislations related to screening tests. U.S. is expected to be a key regional revenue pocket.

Moreover, recommendation of introducing effective screening tests in healthcare sector by EU along with favorable changes in existing tests will drive Europe in-vitro colorectal cancer screening tests industry revenue over the coming years. In addition to this, the growing significance of colorectal cancer screening tests in Europe has significantly reduced the mortality rate. Germany is forecast to make significant contributions towards the regional share.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/451

Market players will try to increase regional presence through strategic alliances and exploration of untapped opportunities in emerging economies. Key industry participants include Eiken Chemical Company Limited, Abbott Molecular, CompanionDx Reference Lab LLC, Alere Incorporation, Sysmex Corporation, Quest Diagnostics, Beckman Coulter, Merck Millipore Corporation, and Epigenomics AG.

Browse Related Reports:

Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers [Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons, Interleukins]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

No comments:

Post a Comment